Wood E - Search Results

1

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.

Lima VD, Sierra-Madero J, Wu Z, Singer J, Wood E, Hull MW, Richard Harrigan P, Montaner JS. Lima VD, et al. Among authors: wood e. J Int AIDS Soc. 2014 May 6;17(1):18617. doi: 10.7448/IAS.17.1.18617. eCollection 2014. J Int AIDS Soc. 2014. PMID: 24805184 Free PMC article. Clinical Trial.

2

Determinants of geographic mobility among participants in a population-based HIV/AIDS drug treatment program.

Wood E, Yip B, Gataric N, Montaner JS, O'Shaughnessy MV, Schechter MT, Hogg RS. Wood E, et al. Health Place. 2000 Mar;6(1):33-40. doi: 10.1016/s1353-8292(99)00028-3. Health Place. 2000. PMID: 10685023

3

Depressive symptoms decline among persons on HIV protease inhibitors.

Low-Beer S, Chan K, Yip B, Wood E, Montaner JS, O'Shaughnessy MV, Hogg RS. Low-Beer S, et al. Among authors: wood e. J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):295-301. doi: 10.1097/00126334-200004010-00003. J Acquir Immune Defic Syndr. 2000. PMID: 10836751

4

Antiretroviral medication use among injection drug users: two potential futures.

Wood E, Schechter MT, Tyndall MW, Montaner JS, O'Shaughnessy MV, Hogg RS. Wood E, et al. AIDS. 2000 Jun 16;14(9):1229-35. doi: 10.1097/00002030-200006160-00021. AIDS. 2000. PMID: 10894288

5

Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.

Wood E, Braitstein P, Montaner JS, Schechter MT, Tyndall MW, O'Shaughnessy MV, Hogg RS. Wood E, et al. Lancet. 2000 Jun 17;355(9221):2095-100. doi: 10.1016/S0140-6736(00)02375-8. Lancet. 2000. PMID: 10902622

6

The end of the line: has rapid transit contributed to the spatial diffusion of HIV in one of Canada's largest metropolitan areas?

Wood E, Chan K, Montaner JS, Schechter MT, Tyndall M, O'Shaughnessy MV, Hogg RS. Wood E, et al. Soc Sci Med. 2000 Sep;51(5):741-8. doi: 10.1016/s0277-9536(99)00479-7. Soc Sci Med. 2000. PMID: 10975233

7

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy.

Wood E, Yip B, Hogg RS, Sherlock CH, Jahnke N, Harrigan RP, O'Shaughnessy MV, Montaner JS. Wood E, et al. AIDS. 2000 Sep 8;14(13):1955-60. doi: 10.1097/00002030-200009080-00011. AIDS. 2000. PMID: 10997400

8

Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents.

Braitstein P, Kendall T, Chan K, Wood E, Montaner JS, O'Shaughnessy MV, Hogg RS. Braitstein P, et al. Among authors: wood e. AIDS. 2001 Mar 9;15(4):532-3. doi: 10.1097/00002030-200103090-00016. AIDS. 2001. PMID: 11242154 No abstract available.

9

Health related quality of life among persons with HIV after the use of protease inhibitors.

Low-Beer S, Chan K, Wood E, Yip B, Montaner JS, O'Shaughnessy MV, Hogg RS. Low-Beer S, et al. Among authors: wood e. Qual Life Res. 2000;9(8):941-9. doi: 10.1023/a:1008985728271. Qual Life Res. 2000. PMID: 11284213

10

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. CMAJ. 2001 Aug 21;165(4):405-10. CMAJ. 2001. PMID: 11531048 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,880 results

Search Page

Filters